TPM Livewire

FDA Reviewing Emergency Contraceptives After Label Change On European Drug

I3zyomkbvwd9ahced8hs
AP Photo

"The FDA is currently reviewing the available and related scientific information on this issue, including the publication upon which the Norlevo labeling change was based," FDA spokeswoman Erica Jefferson wrote in an email to Mother Jones. "The agency will then determine what, if any, labeling changes to approved emergency contraceptives are warranted."